EPS for National Research Corporation (NRC) Expected At $0.27

October 13, 2018 - By Peter Kolinski

Analysts expect National Research Corporation (NASDAQ:NRC) to report $0.27 EPS on November, 6.They anticipate $0.18 EPS change or 200.00 % from last quarter’s $0.09 EPS. NRC’s profit would be $6.68 million giving it 33.71 P/E if the $0.27 EPS is correct. After having $0.28 EPS previously, National Research Corporation’s analysts see -3.57 % EPS growth. The stock decreased 1.59% or $0.59 during the last trading session, reaching $36.41. About 27,724 shares traded. National Research Corporation (NASDAQ:NRC) has risen 15.94% since October 14, 2017 and is uptrending. It has outperformed by 0.32% the S&P500.

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. The company has market cap of $900.75 million. The Company’s portfolio of subscription solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. It has a 42.14 P/E ratio. The firm offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

National Research Corporation (NASDAQ:NRC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.